Back to Journals » Drug Design, Development and Therapy » Volume 13

Endostatin attenuates PDGF-BB- or TGF-β1-induced HSCs activation via suppressing RhoA/ROCK1 signal pathways

Total article views   HTML views PDF downloads Totals
8,059 Dovepress* 7,283+ 1,441 8,724
PubMed Central* 776 240 1,016
Totals 8,059 1,681 9,740
*Since 11 January 2019

View citations on PubMed Central and Google Scholar